Showing posts with label working. Show all posts
Showing posts with label working. Show all posts

People behaved more selfishly and dishonestly when working in a dimly lit room or when wearing sunglasses

Researchers found that people working in a dimly lit room were more likely to cheat about their own performance on a task in order to earn more money than people working in a well-lit room.

Darkness may create a sense of illusory anonymity that disinhibits self-interested and unethical behaviors. It appears to induce a false sense of concealment, leading people to feel that their identities are hidden.

References:
Dim Lighting and Sunglasses Encourage Unethical Behavior in Study. WebMD.
Image source: Ray Ban Original Wayfarer, Wikipedia, Creative Commons Attribution-Share Alike 3.0 Unported license.

Comments from Twitter and Facebook:

@scanman: RT @DrVes: when working in a dimly lit room http://goo.gl/fb/erLEf

@doctorwhitecoat: Clubbing/bars? RT @DrVes People behaved more selfishly/dishonestly when in a dimly lit room or when wearin sunglasses http://goo.gl/fb/erLEf

Mike Cadogan: "Recently started working in the office with the light on...feeling better and more energetic already, though not sure about the selfish/dishonest part..."

Stelara (ustekinumab) and Remicade (infliximab) are effective if Enbrel (etanercept) stops working in psoriasis

About 7.5 million Americans suffer from psoriasis, a lifelong disorder characterized by inflammation of skin and, often, the joints.

Stelara, Remicade, and Enbrel are all biologics -- drugs made of genetically engineered proteins -- that are generally used to treat patients who aren't responding to traditional therapies such as light therapy and methotrexate.

Remicade and Enbrel both block tumor necrosis factor-alpha (TNF-alpha), a chemical produced by immune cells that fuels inflammation, much like gas on a fire. Stelara targets two proteins, interleukin 12 and interleukin 23, that also drive the inflammatory process.

References:
Study Shows Stelara and Remicade Are Both Effective if Enbrel Stops Working. WebMD, 2010.
Ustekinumab is a Strong Option for Moderate to Severe Psoriasis - anti-IL12/23 monoclonal antibody with NNT of 2 http://goo.gl/gbXSJ
Image source: Crystal structure of human IL-12, Wikipedia, public domain.

How-To: Maintain a correct posture while working on your laptop